Cover Image
市場調查報告書

全球疫苗、疫苗接種市場考察,機會分析,市場佔有率,預測

Global Vaccines & Vaccination Market Insights, Opportunity, Analysis, Market Shares and Forecast 2016 - 2022

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 361601
出版日期 內容資訊 英文 140 Pages
商品交期: 請詢問到貨日
價格
Back to Top
全球疫苗、疫苗接種市場考察,機會分析,市場佔有率,預測 Global Vaccines & Vaccination Market Insights, Opportunity, Analysis, Market Shares and Forecast 2016 - 2022
出版日期: 2016年06月23日 內容資訊: 英文 140 Pages
簡介

全球疫苗、疫苗接種市場,預計2016年∼2022年以10.5%的年複合成長率成長。

本報告提供全球疫苗、疫苗接種市場相關調查分析,市場概要,市場決策要素,市場區隔,各地區的市場分析,企業簡介等系統性資訊。

第1章 簡介

第2章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 參數分析
  • 主要市場考察
  • 競爭情形
  • 五力分析模型
  • 主要的購買標準
  • 策略性建議
  • 策略性結論

第3章 市場決策要素

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 市場課題
  • 親市場
  • 競爭市場
  • 替代市場

第4章 市場區隔

  • 各技術
  • 各類型
  • 疾病的各適應症
  • 各終端用戶

第5章 各地區的市場分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 法國
    • 德國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 其他
  • 其他地區

第6章 企業簡介

  • ABBOTT
  • ASTRAZENECA
  • BAVARIAN NORDIC
  • BAXTER
  • BHARAT BIOTECH
  • BIO MED
  • CSL LIMITED
  • EMERGENT BIOSOLUTIONS, INC.
  • GLAXOSMITHKLINE, PLC
  • JOHNSON &JOHNSON
  • MEDIMMUNE, LLC. (ASTRAZENECA的子公司)
  • MERCK & CO., INC.
  • NOVARTIS AG
  • PFIZER, INC.
  • SANOFI

圖表

目錄
Product Code: HBI-430814

The global vaccines & vaccination market is expected to grow at the CAGR of 10.5% during 2016-2022. The market has generated revenue of more than $ 467 million in 2016 and is projected to reach up to $ $769.4 million by 2022. Due to rising use of adjuvants in vaccine-preventable diseases, increasing government investments and initiatives, rising company investments in vaccine development and increasing initiatives by non-government organizations become the major drivers which help to increase the market of vaccines & vaccination globally. Due to increasing prevalence of diseases such as HIV/AIDS, cancer and allergy, there is an increase in the demand of adjuvants vaccine. According to American Academy of Allergy Asthma and Immunology (AAAAI), around 7.8 million children suffered from respiratory allergies worldwide. It is seen that more than 8% population is suffering from food allergy, globally, among which approximately 6% aged 0-2 years, 9% aged 3-5 years and nearly 8% aged 6-10 years, approximately 8% aged 11-13 years and more than 8.5% aged 14-18 years suffer from food allergy globally. The developing regions such as India, China has been on an uprising trend in terms of severity as well as prevalence of diseases. These allergic diseases contain asthma, rhinitis, anaphylaxis, drug, food and insect allergy and many more. Approx. 20% to 30 % of total population suffers from at least one of these allergic diseases in India among which 20% to 30% of the population suffers from allergic rhinitis and 15% have asthma.

On the basis of segmentation the market of vaccines & vaccination is segmented as technology, type, disease indication, and end user. On the basis of technology, the market of vaccines & vaccination is segmented as subunit vaccines, live attenuated vaccines, conjugate vaccines, inactivated vaccines, recombinant vector vaccines, toxoid vaccines, synthetic vaccines, dendritic cell vaccines. Based on types, the market is segmented into preventive vaccines and therapeutic vaccines. Similarly, based on end users the market is segmented as pediatrics and adults.

Geographically, the vaccines &vaccination market is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America has the largest market share of vaccines & vaccination followed by Europe and Asia Pacific. Due to governmental initiatives, and increasing focus of major players in the Indian vaccine technology market, and increasing immunization initiatives by organizations such as World Health Organization and GAVI helps to increase the market of Asia Pacific region.

Some of the major market players are Abbott Astrazeneca, Bavarian Nordic, Baxter, Bharat Biotech, Bio Med, CSL Limited , Emergent Biosolutions, Inc., Glaxosmithkline, PLC, Johnson & Johnson , Medimmune, LLC. (A Subsidiary Of Astrazeneca), Merck & Co., Inc. Acquisition, mergers and expansions are the key strategies adopted by the market players to sustain in the market. For example in 2014, Abbot diagnostic had acquired US based Topera Inc,. a venture backed with medical device company that focuses on electrophysiology technology for diagnosis and treatment of trial fibrillation.

Table of Contents

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. MARKET DEFINITION AND SCOPE
  • 2.2. KEY FINDINGS
  • 2.3. PARAMETRIC TECHNOLOGIES
    • 2.3.1. RAW MATERIAL SUPPLIER
    • 2.3.2. PRODUCTION GEOGRAPHICALLY
    • 2.3.3. ADOPTION ACROSS VARIOUS INDUSTRIES
  • 2.4. KEY MARKET INSIGHTS
    • 2.4.1. TOP 3 EMERGING COUNTRIES
    • 2.4.2. TOP 3 REVENUE GENERATING SEGMENTS
    • 2.4.3. TOP GROWING MARKETS AND EMERGING TRENDS
    • 2.4.4. TOP 3 GEOGRAPHY
  • 2.5. COMPETITIVE LANDSCAPE
    • 2.5.1. MARKET SHARE TECHNOLOGIES
    • 2.5.2. TOP WINNING STRATEGIES
    • 2.5.3. CASE STUDIES: TOP COMPETITIVE MOVES
  • 2.6. PORTER'S FIVE FORCE MODEL
    • 2.6.1. THREAT OF NEW ENTRANTS
    • 2.6.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
    • 2.6.3. BARGAINING POWER OF BUYER
    • 2.6.4. BARGAINING POWER OF SUPPLIER
    • 2.6.5. INTENSITY OF COMPETITIVE RIVALRY
  • 2.7. KEY BUYING CRITERIA
  • 2.8. STRATEGIC RECOMMENDATION
  • 2.9. STRATEGIC CONCLUSIONS

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. RISING USE OF ADJUVANTS IN VACCINE-PREVENTABLE DISEASES
    • 3.1.2. INCREASING GOVERNMENT INVESTMENTS AND INITIATIVES.
    • 3.1.3. RISING COMPANY INVESTMENTS IN VACCINE DEVELOPMENT
    • 3.1.4. INCREASING INITIATIVES BY NON-GOVERNMENT ORGANIZATIONS
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. RISING COST OF RESEARCH
    • 3.2.2. HIGH REGULATORY HURDLES
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. COMBINED ADJUVANTS
    • 3.3.2. VACCINES FOR YOUNG CHILDREN
    • 3.3.3. WIDESPREAD OF DISEASES
    • 3.3.4. INCREASING DEMAND IN EMERGING ECONOMIES
  • 3.4. MARKET CHALLENGES
    • 3.4.1. RECOGNITION OF ADJUVANTS
  • 3.5. PARENT MARKET
  • 3.6. COMPETITORS MARKET
  • 3.7. ALTERNATIVE MARKET

4. MARKET SEGMENTATION

  • 4.1. BY TECHNOLOGY
    • 4.1.1. GLOBAL VACCINES & VACCINATION MARKET BY SUBUNIT VACCINES 2014-2022 ($ MILLION)
    • 4.1.2. GLOBAL VACCINES & VACCINATION MARKET BY LIVE ATTENUATED VACCINES 2014-2022 ($ MILLION)
    • 4.1.3. GLOBAL VACCINES & VACCINATION MARKET BY CONJUGATE VACCINES 2014-2022 ($ MILLION)
    • 4.1.4. GLOBAL VACCINES & VACCINATION MARKET BY INACTIVATED VACCINES 2014-2022 ($ MILLION)
    • 4.1.5. GLOBAL VACCINES & VACCINATION MARKET BY RECOMBINANT VECTOR VACCINES 2014-2022 ($ MILLION)
    • 4.1.6. GLOBAL VACCINES & VACCINATION MARKET BY TOXOID VACCINES 2014-2022 ($ MILLION)
    • 4.1.7. GLOBAL VACCINES & VACCINATION MARKET BY SYNTHETIC VACCINES 2014-2022 ($ MILLION)
    • 4.1.8. GLOBAL VACCINES & VACCINATION MARKET BY DENDRITIC CELL VACCINES 2014-2022 ($ MILLION)
  • 4.2. BY TYPE
    • 4.2.1. GLOBAL VACCINES & VACCINATION MARKET BY PREVENTIVE VACCINES 2014-2022 ($ MILLION)
    • 4.2.2. GLOBAL VACCINES & VACCINATION MARKET BY THERAPEUTIC VACCINES 2014-2022 ($ MILLION)
  • 4.3. BY DISEASE INDICATION
    • 4.3.1. GLOBAL VACCINES & VACCINATION MARKET BY INFECTIOUS DISEASES 2014-2022 ($ MILLION)
      • 4.3.1.1. GLOBAL VACCINES & VACCINATION MARKET BY PNEUMONIA
      • 4.3.1.2. GLOBAL VACCINES & VACCINATION MARKET BY MMR 2014-2022 ($ MILLION)
      • 4.3.1.3. GLOBAL VACCINES & VACCINATION MARKET BY INFLUENZA 2014-2022 ($ MILLION)
      • 4.3.1.4. GLOBAL VACCINES & VACCINATION MARKET BY DTP 2014-2022 ($ MILLION)
      • 4.3.1.5. GLOBAL VACCINES & VACCINATION MARKET BY HEPATITIS 2014-2022 ($ MILLION)
      • 4.3.1.6. GLOBAL VACCINES & VACCINATION MARKET BY ROTAVIRUS 2014-2022 ($ MILLION)
      • 4.3.1.7. GLOBAL VACCINES & VACCINATION MARKET BY VARICELLA 2014-2022 ($ MILLION)
      • 4.3.1.8. GLOBAL VACCINES & VACCINATION MARKET BY MENINGOCOCCAL 2014-2022 ($ MILLION)
      • 4.3.1.9. GLOBAL VACCINES & VACCINATION MARKET BY POLIO 2014-2022 ($ MILLION)
      • 4.3.1.10. GLOBAL VACCINES & VACCINATION MARKET BY OTHERS 2014-2022 ($ MILLION)
    • 4.3.2. GLOBAL VACCINES & VACCINATION MARKET BY CANCER 2014-2022 ($ MILLION)
      • 4.3.2.1. GLOBAL VACCINES & VACCINATION MARKET BY CERVICAL CANCER 2014-2022 ($ MILLION)
      • 4.3.2.2. GLOBAL VACCINES & VACCINATION MARKET BY OTHERS 2014-2022 ($ MILLION)
    • 4.3.3. GLOBAL VACCINES & VACCINATION MARKET BY ALLERGIES 2014-2022 ($ MILLION)
  • 4.4. BY END USERS
    • 4.4.1. GLOBAL VACCINES & VACCINATION MARKET BY PEDIATRICS 2014-2022 ($ MILLION)
    • 4.4.2. GLOBAL VACCINES & VACCINATION MARKET BY ADULTS 2014-2022 ($ MILLION)

5. GEOGRAPHICAL TECHNOLOGIES

  • 5.1. NORTH AMERICA VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
    • 5.1.1. UNITED STATES (U.S.) VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
    • 5.1.2. CANADA VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
  • 5.2. EUROPE VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
    • 5.2.1. UNITED KINGDOM (UK) VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
    • 5.2.2. FRANCE VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
    • 5.2.3. GERMANY VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
    • 5.2.4. SPAIN VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
    • 5.2.5. ITALY VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
    • 5.2.6. ROE VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
  • 5.3. ASIA PACIFIC VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
    • 5.3.1. INDIA VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
    • 5.3.2. CHINA VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
    • 5.3.3. JAPAN VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
    • 5.3.4. KOREA VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
    • 5.3.5. AUSTRALIA VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
    • 5.3.6. ROAPAC VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
  • 5.4. REST OF THE WORLD VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
    • 5.4.1. LATIN AMERICA VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
    • 5.4.2. MENA VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
    • 5.4.3. AFRICA VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)

6. COMPANY PROFILES

  • 1. ABBOTT
  • 2. ASTRAZENECA
  • 3. BAVARIAN NORDIC
  • 4. BAXTER
  • 5. BHARAT BIOTECH
  • 6. BIO MED
  • 7. CSL LIMITED
  • 8. EMERGENT BIOSOLUTIONS, INC.
  • 9. GLAXOSMITHKLINE, PLC
  • 10. JOHNSON &JOHNSON
  • 11. MEDIMMUNE, LLC. (A SUBSIDIARY OF ASTRAZENECA)
  • 12. MERCK &CO., INC.
  • 13. NOVARTIS AG
  • 14. PFIZER, INC.
  • 15. SANOFI

LIST OF TABLE

  • 1. GLOBAL VACCINES & VACCINATION MARKET BY TECHNOLOGY 2014-2022 ($ MILLION)
  • 2. GLOBAL VACCINES & VACCINATION MARKET BY SUBUNIT VACCINES 2014-2022 ($ MILLION)
  • 3. GLOBAL VACCINES & VACCINATION MARKET BY LIVE ATTENUATED VACCINES 2014-2022 ($ MILLION)
  • 4. GLOBAL VACCINES & VACCINATION MARKET BY CONJUGATE VACCINES 2014-2022 ($ MILLION)
  • 5. GLOBAL VACCINES & VACCINATION MARKET BY INACTIVATED VACCINES 2014-2022 ($ MILLION)
  • 6. GLOBAL VACCINES & VACCINATION MARKET BY RECOMBINANT VECTOR VACCINES 2014-2022 ($ MILLION)
  • 7. GLOBAL VACCINES & VACCINATION MARKET BY TOXOID VACCINES 2014-2022 ($ MILLION)
  • 8. GLOBAL VACCINES & VACCINATION MARKET BY SYNTHETIC VACCINES 2014-2022 ($ MILLION)
  • 9. GLOBAL VACCINES & VACCINATION MARKET BY DENDRITIC CELL VACCINES 2014-2022 ($ MILLION)
  • 10. GLOBAL VACCINES & VACCINATION MARKET BY TYPE 2014-2022 ($ MILLION)
  • 11. GLOBAL VACCINES & VACCINATION MARKET BY PREVENTIVE VACCINES 2014-2022 ($ MILLION)
  • 12. GLOBAL VACCINES & VACCINATION MARKET BY THERAPEUTIC VACCINES 2014-2022 ($ MILLION)
  • 13. GLOBAL VACCINES & VACCINATION MARKET BY DISEASE INDICATION 2014-2022($MILLION
  • 14. GLOBAL VACCINES & VACCINATION MARKET BY INFECTIOUS DISEASES 2014-2022 ($ MILLION)
  • 15. GLOBAL VACCINES & VACCINATION MARKET BY PNEUMONIA 2014-2022 ($ MILLION)
  • 16. GLOBAL VACCINES & VACCINATION MARKET BY MMR 2014-2022 ($ MILLION)
  • 17. GLOBAL VACCINES & VACCINATION MARKET BY INFLUENZA 2014-2022 ($ MILLION)
  • 18. GLOBAL VACCINES & VACCINATION MARKET BY DTP 2014-2022 ($ MILLION)
  • 19. GLOBAL VACCINES & VACCINATION MARKET BY HEPATITIS 2014-2022 ($ MILLION)
  • 20. GLOBAL VACCINES & VACCINATION MARKET BY ROTAVIRUS 2014-2022 ($ MILLION)
  • 21. GLOBAL VACCINES & VACCINATION MARKET BY VARICELLA 2014-2022 ($ MILLION)
  • 22. GLOBAL VACCINES & VACCINATION MARKET BY MENINGOCOCCAL 2014-2022 ($ MILLION)
  • 23. GLOBAL VACCINES & VACCINATION MARKET BY POLIO 2014-2022 ($ MILLION)
  • 24. GLOBAL VACCINES & VACCINATION MARKET BY OTHERS 2014-2022 ($ MILLION)
  • 25. GLOBAL VACCINES & VACCINATION MARKET BY CANCER 2014-2022 ($ MILLION)
  • 26. GLOBAL VACCINES & VACCINATION MARKET BY CERVICAL CANCER 2014-2022 ($ MILLION)
  • 27. GLOBAL VACCINES & VACCINATION MARKET BY OTHERS 2014-2022 ($ MILLION)
  • 28. GLOBAL VACCINES & VACCINATION MARKET BY ALLERGIES 2014-2022 ($ MILLION)
  • 29. GLOBAL VACCINES & VACCINATION MARKET BY END USERS 2014-2022($MILLION
  • 30. GLOBAL VACCINES & VACCINATION MARKET BY PEDIATRICS 2014-2022 ($ MILLION)
  • 31. GLOBAL VACCINES & VACCINATION MARKET BY ADULTS 2014-2022 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL VACCINES & VACCINATION MARKET BY TECHNOLOGY 2014-2022 ($ MILLION)
  • 2. GLOBAL VACCINES & VACCINATION MARKET BY SUBUNIT VACCINES 2014-2022 ($ MILLION)
  • 3. GLOBAL VACCINES & VACCINATION MARKET BY LIVE ATTENUATED VACCINES 2014-2022 ($ MILLION)
  • 4. GLOBAL VACCINES & VACCINATION MARKET BY CONJUGATE VACCINES 2014-2022 ($ MILLION)
  • 5. GLOBAL VACCINES & VACCINATION MARKET BY INACTIVATED VACCINES 2014-2022 ($ MILLION)
  • 6. GLOBAL VACCINES & VACCINATION MARKET BY RECOMBINANT VECTOR VACCINES,2014-2022 ($ MILLION)
  • 7. GLOBAL VACCINES & VACCINATION MARKET BY TOXOID VACCINES 2014-2022 ($ MILLION)
  • 8. GLOBAL VACCINES & VACCINATION MARKET BY SYNTHETIC VACCINES 2014-2022 ($ MILLION)
  • 9. GLOBAL VACCINES & VACCINATION MARKET BY DENDRITIC CELL VACCINES 2014-2022 ($ MILLION)
  • 10. GLOBAL VACCINES & VACCINATION MARKET BY TYPE 2014-2022 ($ MILLION)
  • 11. GLOBAL VACCINES & VACCINATION MARKET BY PREVENTIVE VACCINES 2014-2022 ($ MILLION)
  • 12. GLOBAL VACCINES & VACCINATION MARKET BY THERAPEUTIC VACCINES 2014-2022 ($ MILLION)
  • 13. GLOBAL VACCINES & VACCINATION MARKET BY DISEASE INDICATION 2014-2022($MILLION
  • 14. GLOBAL VACCINES & VACCINATION MARKET BY INFECTIOUS DISEASES 2014-2022 ($ MILLION)
  • 15. GLOBAL VACCINES & VACCINATION MARKET BY PNEUMONIA 2014-2022 ($ MILLION)
  • 16. GLOBAL VACCINES & VACCINATION MARKET BY MMR 2014-2022 ($ MILLION)
  • 17. GLOBAL VACCINES & VACCINATION MARKET BY INFLUENZA 2014-2022 ($ MILLION)
  • 18. GLOBAL VACCINES & VACCINATION MARKET BY DTP 2014-2022 ($ MILLION)
  • 19. GLOBAL VACCINES & VACCINATION MARKET BY HEPATITIS 2014-2022 ($ MILLION)
  • 20. GLOBAL VACCINES & VACCINATION MARKET BY ROTAVIRUS 2014-2022 ($ MILLION)
  • 21. GLOBAL VACCINES & VACCINATION MARKET BY VARICELLA 2014-2022 ($ MILLION)
  • 22. GLOBAL VACCINES & VACCINATION MARKET BY MENINGOCOCCAL 2014-2022 ($ MILLION)
  • 23. GLOBAL VACCINES & VACCINATION MARKET BY POLIO 2014-2022 ($ MILLION)
  • 24. GLOBAL VACCINES & VACCINATION MARKET BY OTHERS 2014-2022 ($ MILLION)
  • 25. GLOBAL VACCINES & VACCINATION MARKET BY CANCER 2014-2022 ($ MILLION)
  • 26. GLOBAL VACCINES & VACCINATION MARKET BY CERVICAL CANCER 2014-2022 ($ MILLION)
  • 27. GLOBAL VACCINES & VACCINATION MARKET BY OTHERS 2014-2022 ($ MILLION)
  • 28. GLOBAL VACCINES & VACCINATION MARKET BY ALLERGIES 2014-2022 ($ MILLION)
  • 29. GLOBAL VACCINES & VACCINATION MARKET BY END USERS 2014-2022($MILLION
  • 30. GLOBAL VACCINES & VACCINATION MARKET BY PEDIATRICS 2014-2022 ($ MILLION)
  • 31. GLOBAL VACCINES & VACCINATION MARKET BY ADULTS 2014-2022 ($ MILLION)
Back to Top